title: Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): a status quo.
authors.affiliation: Department of Internal Medicine, Hematology and Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.
authors.forename: Ali T
authors.initials: AT
authors.lastname: Taher
authors.affiliation: Department of Internal Medicine, Hematology and Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon.
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Musallam
authors.affiliation: Division of Hematology and Oncology, Department of Pediatrics and Thalassemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
authors.forename: Vip
authors.initials: V
authors.lastname: Viprakasit
authors.affiliation: Department of Hematology, University College London, London, UK.
authors.forename: John B
authors.initials: JB
authors.lastname: Porter
authors.affiliation: Department of Clinical Sciences and Community, University of Milan, IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.
authors.forename: Maria Domenica
authors.initials: MD
authors.lastname: Cappellini
mesh_terms: D015913:Chelation Therapy; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D013789:Thalassemia / Q000150:complications / Q000188:drug therapy*; D065227:Transfusion Reaction
chemical_list: D007502:Iron Chelating Agents